Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model von Varghese, Bindu, Lynch, Lydia, Vriend, Lianne E., Draganov, Dobrin, Clark, Justice M., Kissick, Haydn T., Varghese, Sharlin, Sanda, Martin G., Dranoff, Glenn, Arredouani, M. Simo, Balk, Steven P., Exley, Mark A.

Volltext

A Novel Strategy for Off-the-Shelf T Cell Therapy Which Evades Allogeneic T Cell and NK Cell Rejection von Zhang, Yong, Goel, Surbhi, Prodeus, Aaron, Jetley, Utsav, Tan, Yiyang, Averill, John, Ranade, Utkarsha, Balwani, Ishina, Dutta, Ivy, Sharma, Palak, Venkatesan, Priya, Liu, Dai, Roy, Matthew, O′Connell, Daniel, Arredouani, Simo M, Keenan, Marie, Lescarbeau, Reynald, Schultes, Birgit C

Volltext

Androgens modulate anti-tumor immunity through interference with the T lymphocyte differentiation program (P1169) von Arredouani, M. Simo, Kissick, Haydn, Dunn, Laura, Sanda, Martin

Volltext

Immunogenic Peptides Derived from the Transcription Factor ERG as a Vaccine for Prostate Cancer (162.17) von Kissick, Haydn, Dunn, Laura, Lu, Bin, Sanda, Martin, Arredouani, M. Simo

Volltext

Breaking immune tolerance to prostate-associated tumor antigens through Tim-1 receptor (162.20) von Arredouani, M. Simo, Kissick, Haydn, Dunn, Laura, Strom, Terry, Sanda, Martin

Volltext

Exploiting the Good Guys: Th1 Antiviral & Antitumor Human & Mouse NKT Cells von Exley, Mark, Nowak, Michael, Yue, Simon, Scheuplein, Felix, Arredouani, M. Simo, Sanda, Martin, Sasada, Tetsuro, Balk, Steven

Volltext